Sharon M Weinstein

Summary

Affiliation: University of Utah
Country: USA

Publications

  1. ncbi request reprint Integrating palliative care in oncology
    S M Weinstein
    Pain Medicine and Palliative Care Program at the Huntsman Cancer Institute at the University of Utah, Salt Lake City, 84112, USA
    Cancer Control 8:32-5. 2001
  2. ncbi request reprint Integrating palliative care in pediatrics
    Sharon M Weinstein
    University of Utah, Huntsman Cancer Institute, 2000 Circle of Hope, Room 2151, Salt Lake City, UT 84112, USA
    Curr Pain Headache Rep 8:281-3. 2004
  3. pmc A new extended release formulation (OROS) of hydromorphone in the management of pain
    Sharon M Weinstein
    University of Utah, Huntsman Cancer Institute, Salt Lake City, Utah, USA
    Ther Clin Risk Manag 5:75-80. 2009
  4. ncbi request reprint Documentation of pain in comprehensive cancer centers in the United States: a preliminary analysis
    Sharon M Weinstein
    Department of Anesthesiology, Neurology and Oncology, University of Utah, Huntsman Cancer Institute, 2000 Circle of Hope, Salt Lake City, Utah 84112, USA
    J Natl Compr Canc Netw 2:173-80. 2004
  5. ncbi request reprint Management of pain associated with spinal tumor
    Sharon M Weinstein
    Huntsman Cancer Institute, University of Utah, Suite 2100, 2000 Circle of Hope, Salt Lake City, UT 84112, USA
    Neurosurg Clin N Am 15:511-27. 2004
  6. ncbi request reprint Lessons learned from the case of Theresa Marie Schiavo: one palliative care doctor's perspective
    Sharon M Weinstein
    University of Utah, Huntsman Cancer Institute, 2000 Circle of Hope, Room 2151, Salt Lake City, UT 84112, USA
    Curr Pain Headache Rep 9:223-5. 2005
  7. ncbi request reprint Multicenter, open-label, prospective evaluation of the conversion from previous opioid analgesics to extended-release hydromorphone hydrochloride administered every 24 hours to patients with persistent moderate to severe pain
    Sharon M Weinstein
    MD Anderson Cancer Center, University o f Texas, Houston, Texas, USA
    Clin Ther 28:86-98. 2006
  8. doi request reprint Fentanyl buccal tablet for the treatment of breakthrough pain in opioid-tolerant patients with chronic cancer pain: A long-term, open-label safety study
    Sharon M Weinstein
    Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah 84112, USA
    Cancer 115:2571-9. 2009
  9. doi request reprint A spicamycin derivative (KRN5500) provides neuropathic pain relief in patients with advanced cancer: a placebo-controlled, proof-of-concept trial
    Sharon M Weinstein
    Pain Medicine and Palliative Care Program, The Huntsman Cancer Institute, Salt Lake City, UT, USA
    J Pain Symptom Manage 43:679-93. 2012
  10. ncbi request reprint Sedation for comfort at end of life
    Olivia Walton
    Huntsman Cancer Institute, University of Utah, 2000 E Circle of Hope, Salt Lake City, UT 84112, USA
    Curr Pain Headache Rep 6:197-201. 2002

Detail Information

Publications12

  1. ncbi request reprint Integrating palliative care in oncology
    S M Weinstein
    Pain Medicine and Palliative Care Program at the Huntsman Cancer Institute at the University of Utah, Salt Lake City, 84112, USA
    Cancer Control 8:32-5. 2001
    ..The World Health Organization has mandated an integrated approach to palliative care in the treatment of patients with cancer. However, medical decision making in the setting of life-threatening disease remains complicated...
  2. ncbi request reprint Integrating palliative care in pediatrics
    Sharon M Weinstein
    University of Utah, Huntsman Cancer Institute, 2000 Circle of Hope, Room 2151, Salt Lake City, UT 84112, USA
    Curr Pain Headache Rep 8:281-3. 2004
    ..This care plan will act as a foundation to assist and guide all providers, from the primary pediatrician to the subspecialty surgeon, in providing interventions that will most benefit a child and add life to the child's years...
  3. pmc A new extended release formulation (OROS) of hydromorphone in the management of pain
    Sharon M Weinstein
    University of Utah, Huntsman Cancer Institute, Salt Lake City, Utah, USA
    Ther Clin Risk Manag 5:75-80. 2009
    ..Optimizing pain management for the individual patient may require sequential trials of opioid medications until the regimen with the most favorable therapeutic ratio of efficacy to side effects is determined...
  4. ncbi request reprint Documentation of pain in comprehensive cancer centers in the United States: a preliminary analysis
    Sharon M Weinstein
    Department of Anesthesiology, Neurology and Oncology, University of Utah, Huntsman Cancer Institute, 2000 Circle of Hope, Salt Lake City, Utah 84112, USA
    J Natl Compr Canc Netw 2:173-80. 2004
    ....
  5. ncbi request reprint Management of pain associated with spinal tumor
    Sharon M Weinstein
    Huntsman Cancer Institute, University of Utah, Suite 2100, 2000 Circle of Hope, Salt Lake City, UT 84112, USA
    Neurosurg Clin N Am 15:511-27. 2004
    ..Patients and their families are best served by the provision of supportive care by specialty pain medicine and palliative care services (especially neurology based) working with the primary neurosurgical team in an integrated model...
  6. ncbi request reprint Lessons learned from the case of Theresa Marie Schiavo: one palliative care doctor's perspective
    Sharon M Weinstein
    University of Utah, Huntsman Cancer Institute, 2000 Circle of Hope, Room 2151, Salt Lake City, UT 84112, USA
    Curr Pain Headache Rep 9:223-5. 2005
  7. ncbi request reprint Multicenter, open-label, prospective evaluation of the conversion from previous opioid analgesics to extended-release hydromorphone hydrochloride administered every 24 hours to patients with persistent moderate to severe pain
    Sharon M Weinstein
    MD Anderson Cancer Center, University o f Texas, Houston, Texas, USA
    Clin Ther 28:86-98. 2006
    ..Hydromorphone hydrochloride is a mu-opioid agonist with dose-dependent analgesic properties. Extended-release hydromorphone hydrochloride (ER hydromorphone HCl) capsules have been developed for administration every 24 hours...
  8. doi request reprint Fentanyl buccal tablet for the treatment of breakthrough pain in opioid-tolerant patients with chronic cancer pain: A long-term, open-label safety study
    Sharon M Weinstein
    Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah 84112, USA
    Cancer 115:2571-9. 2009
    ....
  9. doi request reprint A spicamycin derivative (KRN5500) provides neuropathic pain relief in patients with advanced cancer: a placebo-controlled, proof-of-concept trial
    Sharon M Weinstein
    Pain Medicine and Palliative Care Program, The Huntsman Cancer Institute, Salt Lake City, UT, USA
    J Pain Symptom Manage 43:679-93. 2012
    ..Neuropathic pain in patients with cancer can be difficult to treat effectively...
  10. ncbi request reprint Sedation for comfort at end of life
    Olivia Walton
    Huntsman Cancer Institute, University of Utah, 2000 E Circle of Hope, Salt Lake City, UT 84112, USA
    Curr Pain Headache Rep 6:197-201. 2002
    ..The following is a discussion of the clinical skills and ethical considerations that health care providers should have when treating terminal patients with cancer...
  11. ncbi request reprint Adult cancer pain
    Robert Swarm
    National Comprehensive Cancer Network
    J Natl Compr Canc Netw 5:726-51. 2007
  12. ncbi request reprint Palliative care. Clinical practice guidelines in oncology
    Michael H Levy
    Fox Chase Cancer Center
    J Natl Compr Canc Netw 4:776-818. 2006